Publikationsdatenbank

Evidenz-basierte Diagnose und Therapie der Ketose bei Milchkühen (2022)

Art

Zeitschriftenartikel / wissenschaftlicher Beitrag

Autoren

Borchardt, Stefan (WE 19)

Venjakob, Peter Lennart (WE 19)

Quelle

Tierärztliche Umschau : Pferd & Nutztier

Bandzählung: 2022

Heftzählung: 1

Seiten: 12 – 17

ISSN: 2702-2013

Sprache

Englisch

Verweise

URL (Volltext): https://www.researchgate.net/publication/359471091_Evidenz-basierte_Diagnose_und_Therapie_der_Ketose_bei_Milchkuhen

Kontakt

Tierklinik für Fortpflanzung

Königsweg 65
Haus 27
14163 Berlin
+49 30 838 62618
fortpflanzungsklinik@vetmed.fu-berlin.de

Abstract / Zusammenfassung

Hyperketonemia (ß-hydroxybutyrate (BHBA) ≥ 1,2 mmol/L) affects over 40% of dairy cows in early lactation. Negative impacts of hyperketonemia most notably include decreased milk yield, increased risk for other clinical diseases (e.g., displaced abomasum, metritis, mastitis), and increased risk for early lactation herd removal. Cowside blood BHBA tests are now available for rapid and accurate diagnosis of hyperketonemia. Urine and milk tests can also be used, but have substantial disadvantages. Accurate and early diagnosis of hyperketonemia after calving allows early and effective treatment. This mitigates about half of the negative impacts of hyperketonemia such as decreased milk yield, increased risk for displaced abomasum, and increased risk for herd removal. Mild to moderate cases of hyperketonemia in individual cows are treated best with an oral glucose precursor such as propylene glycol. Intravenous glucose should be reserved for severe cases and followed with oral glucose precursors. Dexamethasone as an adjunct therapy to propylene glycol cannot be recommended. Vitamin B12might be a good option for HYK therapy.